Acción 300244 DIAN DIAGNOSTICS GROUP CO.,LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Dian Diagnostics Group Co.,Ltd.

Acciones

300244

CNE1000015N1

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 14/06/2024 		Varia. Cinco días. Varia. 1 de enero.
13,13 CNY +1,86 % Gráfico intradía de Dian Diagnostics Group Co.,Ltd. +1,70 % -44,86 %
26/04 Dian Diagnostics Group Co.,Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
19/04 Dian Diagnostics Group Co.,Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Dian Diagnostics Group Co.,Ltd. Announces Dividend on share A for the Year 2023, Payable on June 13, 2024
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Dian Diagnostics Group Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
Dian Diagnostics Group Co.,Ltd. authorizes a Buyback Plan.
Dian Diagnostics Expands to Middle East With UAE Collaboration
Dian Diagnostics Group Co.,Ltd. Announces Executive Appointments
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Dian Diagnostics Group Co.,Ltd. Announces Final Cash Dividend for A Shares, Payable on 31 May 2023
Dian Diagnostics Group Co.,Ltd. Approves Cash Dividend for 2022
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Dian Diagnostics Group Co.,Ltd. Announces the Profit Distribution Proposal for 2022
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Geneus Tech announced that it has received funding from GF Xinde Investment Management Co., Ltd, Dian Diagnostics Group Co.,Ltd.
Tranche Update on Dian Diagnostics Group Co.,Ltd.'s Equity Buyback Plan announced on December 7, 2022.
Dian Diagnostics Group Co.,Ltd.'s Equity Buyback announced on December 7, 2022, has expired with 1,918,600 shares, representing 0.31% for CNY 49.99 million.
Tranche Update on Dian Diagnostics Group Co.,Ltd.'s Equity Buyback Plan announced on December 7, 2022.
Dian Diagnostics' Unit Plans to Buy Alta Scientific
As China seeks to live with the virus, COVID-control industries face decline
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300244
  4. Noticias Dian Diagnostics Group Co.,Ltd.
  5. Otros idiomas